Studie på effekten av rifampicin och ursodeoxycholsyra på gallipider och deras transport och avgiftning hos patienter med kolesterolgallstenar.

• Conditions: Gallstone disease

• Registration Number: EUCTR2005-005843-24-SE
• Lead Sponsor: Hanns-Ulrich Marschall

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2005-12-30
• Last Update Posted: 19 March 2012

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Gallstone disease, scheduled for laparascopic cholecystectomy
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Pregnancy and previous or ongoing liver, kidney, intestinal or metabolic diseases, as well as the use of medications known to affect liver function and metabolism, e.g. lipid or glucose lowering drugs, P450 enzyme inducers

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified